GATA2 and hematologic disorder: Base editing and prime editing are the recent promising and rigorous refinements of genome editing technologies which could provide and improve a patient specific mutation correction for GATA2 mutations or any other gene mutations that predispose to hematological malignancies when potentials and risks of these tools are tested sufficiently prior to the actual patient treatments.